10 Year Anniversary of Actelion
Now full member of Interpharma, the Swiss Association of Pharmaceutical Research Companies
Advertisement
Actelion Ltd announced that the biopharmaceutical company is celebrating its 10 year anniversary. On that occasion, the company is becoming a full member of Interpharma, the association of Swiss pharmaceutical research companies.
Jean-Paul Clozel, M.D. and Chief Executive Officer commented: "In only 10 years, Actelion has grown from a start-up with five founding team members into a profitable global biopharmaceutical company with three marketed products and a rapidly expanding pipeline, with five products expected in the final stages of clinical development by year-end. Actelion, therefore, is well prepared for the next 10 years of innovation and growth, especially thanks to our outstanding work force of close to 1600 employees."
"We are proud to welcome Actelion as a new full member," commented Thomas Cueni, Secretary General of Interpharma. "The success story of Actelion is a reflection of the dynamics and strength of Switzerland as a location for pharmaceutical research companies. Continued favourable conditions for a highly innovative and globally competitive industry are the main mission of Interpharma."